CLINICAL_TRIALS
trial_result
· 2014-12-31
Clinical Trial Update: The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin [Phase 1]
Summary
Phase 1 study assessing whether BIA 2-093 alters the steady-state pharmacokinetics of digoxin.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2014-12-31